Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

NCT07516353 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT07516353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07516353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 20, 2026
Completion date
December 31, 2030
Enrollment
143 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia ,lymphomas, acute myeloid leukemia, all, aml, ewing sarcoma, medulloblastoma, osteosarcoma, rhabdomyosarcoma, sarcoma